Bipin Patel
Bipin Patel is CEO & Founder of electronRx, a deep tech team of interdisciplinary scientists and engineers developing novel technologies to sense the physiological environment and inform personalized therapeutic interventions. Dr. Patel is an entrepreneur with over 20 years of biomedical engineering, drug development and commercialization experience. He previously held leadership roles at big pharma like Merck KGaA, GSK and Pierre Fabre.
-
MedCity Influencers, BioPharma
Winding Back the Ageing Process Using Biological Clocks
Biological clocks could play an important role in helping to promote healthy ageing and to stem the growing incidence of age-related diseases by improving the quality of life of the aged, reducing mortality and relieving the burden on overwhelmed health and social care resources.
-
MedCity Influencers, Health Tech
COPD Diagnosis and Management: The Need for Better Solutions
There is an urgent need to develop solutions that can enable the early diagnosis of COPD as any delays in the diagnosis of COPD represent a missed opportunity to slow disease progression through preventative interventions. Smoking cessation alone could save as many as 120,000 lives per year in the US alone.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Influencers, Health Tech
Why better heart health worldwide is now within reach
By placing the power to detect atrial fibrillation into the hands of 6 billion global smartphone users, validation of further physiological parameters will be expedited and the subsequent adoption of this technology into DTx will enable the low-cost tools required to remove barriers to care and improve heart health across the globe.
-
MedCity Influencers, Artificial Intelligence
Atrial fibrillation in primary care: Why a proactive approach is needed
The key challenge for primary care is the current lack of means for population-wide screening as this significantly lowers our ability to catch the condition early in patients within this golden window.
-
MedCity Influencers, Artificial Intelligence
The role of AI in advancing neuromodulation treatment for epilepsy
Vagus nerve stimulation devices still have a long way to go, but the therapeutic potential of the vagus nerve, the advent of AI and machine learning in healthcare and the opportunity to establish truly personalized digital medicine are enough to warrant further exploration into VNS.
-
Hospitals, MedCity Influencers
As emergency department admissions rise again, how can AI tackle crowding once and for all?
ED crowding is therefore an issue in the healthcare landscape where desperate need for change is meeting huge potential for innovation, and an international consortium should be formed to capitalize on this convergence.
-
MedCity Influencers, Employee Benefits
Quantifying stress & anxiety: Why corporate wellness programs will play a pivotal role in this paradigm shift
Establishing digital biomarkers which correlate physiological parameters with mental health and wellbeing not only has the potential to provide more reliable tools for guiding diagnosis and evaluating patient outcomes but will also improve our understanding of the pathophysiology of mental disorders
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
